Research & Development



京師故事︰凡縉紳陪吊于喪家者,聞前輩至,則易吉服相見;然有易有不易者,以來客之未必皆前輩也。余陪吊于座主甘大司馬家,忽聞徐蝶園相公來,則滿堂盡吉服矣。公名元夢,康熙癸丑進士,與韓慕廬同年,滿朝公卿,皆其後輩。時年九十余,短身赤鼻,面少須髯。詩宗盛唐。《送人出塞》雲︰“君到居庸北,應憐一雁回。沙平疑地盡,山豁訝天開。落日重關閉,秋風萬馬來。勉旃從此役,莫上望鄉台。”大學士舒公赫德,其孫也。天天色 天天she 天天色综合 四川崇寧縣蔡酣紫先生,好道術,與漢陽太守王某交好。王年九十余,能馭空而行。言元時玉山堂主人顧阿瑛已成地仙,至今猶在青城山中。引蔡見之︰綠鬢朱顏,不食不飲,談笑不異常人;說元末明初之事尤詳。王善畫古松,題雲︰“煙墨一螺香一炷,寫出長松兩三樹。月明老鶴忽飛來,踏枝不著空歸去。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo